ReViral is a UK-based biotechnology company developing first-in-class drugs to treat RSV infections.

Biotechnology

ReViral

ReViral's headquarters in Stevenage, United Kingdom

Alex C. Sapir

Cora Griffin

Brett Haumann

Stuart Cockerill

Eddy Littler

Chau Q. Khuong

Lawrence Blatt

Jason Zhou

Ken Powell

Iain D. Dukes

Raphaël Wisniewski

Richard N. Kender

Ron Hunt

The Business Operations team at ReViral is responsible for optimizing internal processes and ensuring efficient resource allocation to support the development of innovative therapies for RSV infections. This team collaborates across departments to streamline project management, enhance strategic planning, and drive operational excellence, ultimately facilitating the company’s mission to deliver groundbreaking treatments.

Business Operations

The Research and Development team at ReViral is dedicated to advancing innovative therapies for RSV infections. Led by experts in virology and preclinical development, the team focuses on discovering and optimizing drug candidates, conducting rigorous preclinical studies, and collaborating strategically to bring groundbreaking treatments from the lab to clinical trials. Their work is pivotal in addressing the urgent medical needs associated with RSV.

Research and Development

The Leadership Team at ReViral is responsible for guiding the company's strategic direction, ensuring financial health, and overseeing the development of innovative treatments for RSV infections. This team collaborates to align scientific research with business objectives, navigate regulatory pathways, and drive operational excellence, all while fostering a culture of innovation and collaboration within the organization.

ReViral

Org chart

Board & advisors

Teams

Business Operations

Research and Development

Leadership Team

Offices

ReViral

Org chart

Board & advisors

Teams

Business Operations

Research and Development

Leadership Team

Offices

Related companies